243 related articles for article (PubMed ID: 25030324)
1. Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region.
Salman-Monte TC; Torrente-Segarra V; Muñoz-Ortego J; Mojal S; Carbonell-Abelló J
Rheumatol Int; 2015 Mar; 35(3):509-15. PubMed ID: 25030324
[TBL] [Abstract][Full Text] [Related]
2. Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus.
Mendoza-Pinto C; García-Carrasco M; Sandoval-Cruz H; Escárcega RO; Jiménez-Hernández M; Etchegaray-Morales I; Soto-Vega E; Muñoz-Guarneros M; López-Colombo A; Delezé-Hinojosa M; Cervera R
Clin Rheumatol; 2009 Jan; 28(1):65-70. PubMed ID: 18670734
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
4. Sedentary behavior does not predict low BMD nor fracture-population-based Canadian Multicentre Osteoporosis Study.
Guðmundsdóttir SL; Berger C; Macdonald H; Adachi JD; Hopman WM; Kaiser SM; Kovacs CS; Davison KS; Morin SN; Goltzman D; ; Prior JC
J Bone Miner Res; 2024 Apr; 39(3):231-240. PubMed ID: 38477796
[TBL] [Abstract][Full Text] [Related]
5. Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions.
Rios-Fernández R; Callejas-Rubio JL; Fernández-Roldán C; Simeón-Aznar CP; García-Hernández F; Castillo-García MJ; Fonollosa Pla V; Barnosi Marín AC; González-Gay MÁ; Ortego-Centeno N
Clin Exp Rheumatol; 2012; 30(6):905-11. PubMed ID: 22935485
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.
Bultink IE; Lems WF; Kostense PJ; Dijkmans BA; Voskuyl AE
Arthritis Rheum; 2005 Jul; 52(7):2044-50. PubMed ID: 15986345
[TBL] [Abstract][Full Text] [Related]
7. Disease Damage Accrual and Low Bone Mineral Density in Female Patients with Systemic Lupus Erythematosus.
Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Ríos-Fernández R; Rueda-Medina B; Ortego-Centeno N
Biol Res Nurs; 2021 Oct; 23(4):575-583. PubMed ID: 33787331
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
Alcalde Vargas A; Pascasio Acevedo JM; Gutiérrez Domingo I; García Jiménez R; Sousa Martín JM; Ferrer Ríos MT; Sayago Mota M; Giráldez Gallego A; Gómez Bravo MA
Transplant Proc; 2012; 44(6):1496-8. PubMed ID: 22841194
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids.
Yeap SS; Othman AZ; Zain AA; Chan SP
Int J Rheum Dis; 2012 Feb; 15(1):17-24. PubMed ID: 22324943
[TBL] [Abstract][Full Text] [Related]
10. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study.
Samelson EJ; Broe KE; Xu H; Yang L; Boyd S; Biver E; Szulc P; Adachi J; Amin S; Atkinson E; Berger C; Burt L; Chapurlat R; Chevalley T; Ferrari S; Goltzman D; Hanley DA; Hannan MT; Khosla S; Liu CT; Lorentzon M; Mellstrom D; Merle B; Nethander M; Rizzoli R; Sornay-Rendu E; Van Rietbergen B; Sundh D; Wong AKO; Ohlsson C; Demissie S; Kiel DP; Bouxsein ML
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):34-43. PubMed ID: 30503163
[TBL] [Abstract][Full Text] [Related]
11. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.
Sinigaglia L; Varenna M; Binelli L; Zucchi F; Ghiringhella D; Gallazzi M; Limonta M; Zeni S; Fantini F
J Rheumatol; 1999 Jun; 26(6):1280-4. PubMed ID: 10381043
[TBL] [Abstract][Full Text] [Related]
12. Determinants of bone mineral density in stable kidney transplant recipients.
Gupta AK; Huang M; Prasad GV
J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus.
Furukawa M; Kiyohara C; Tsukamoto H; Mitoma H; Kimoto Y; Uchino A; Nakagawa M; Oryoji K; Shimoda T; Akashi K; Harada M; Horiuchi T
Rheumatol Int; 2011 Mar; 31(3):365-76. PubMed ID: 20020143
[TBL] [Abstract][Full Text] [Related]
14. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.
Mok CC; Wong SN; Ma KM
Rheumatology (Oxford); 2012 Mar; 51(3):468-75. PubMed ID: 22096013
[TBL] [Abstract][Full Text] [Related]
15. Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus.
Lilleby V; Lien G; Frey Frøslie K; Haugen M; Flatø B; Førre Ø
Arthritis Rheum; 2005 Jul; 52(7):2051-9. PubMed ID: 15986346
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in women with systemic lupus erythematosus.
Bhattoa HP; Bettembuk P; Balogh A; Szegedi G; Kiss E
Clin Rheumatol; 2002 May; 21(2):135-41. PubMed ID: 12086164
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of fragility fractures in systemic lupus erythematosus.
Yee CS; Crabtree N; Skan J; Amft N; Bowman S; Situnayake D; Gordon C
Ann Rheum Dis; 2005 Jan; 64(1):111-3. PubMed ID: 15608308
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus.
Sun YN; Feng XY; He L; Zeng LX; Hao ZM; Lv XH; Pu D
Biomed Res Int; 2015; 2015():510514. PubMed ID: 25738154
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors.
Souto MI; Coelho A; Guo C; Mendonça LM; Pinheiro MF; Papi JA; Farias ML
J Clin Densitom; 2012; 15(3):320-7. PubMed ID: 22321657
[TBL] [Abstract][Full Text] [Related]
20. Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.
Lai CC; Chen WS; Chang DM; Tsao YP; Wu TH; Chou CT; Tsai CY
Osteoporos Int; 2015 Feb; 26(2):601-10. PubMed ID: 25270396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
